• Serina Therapeutics, Inc. Closes $9.5 Million Financing Round More... 

• Enerkem Raises $60 Million in Latest Financing Round More... 

• General Electric Company (GE) Furthers Investment in RIS with Latest Release More...

 

• Esperance Pharmaceuticals, Inc. Completes $7.5 Million Series B Financing More... 

• Shield Therapeutics Raises EUR8.2 Million From Inventages Venture Capital Via Series A Institutional Round More...

• Evotec AG (EVTG.F) Acquires Compound Management Business From Galapagos NV (GLPG.BR); Galapagos to Get 10.25 EUR Million Upfront More... 

• Novartis AG Eyes Consumer, Veterinary Purchases Up to $3 Billion, Chief Says More...

 

• VWR International, Inc. Acquires BioExpress Corp. More... 

• Grifols and Talecris Biotherapeutics (TLCR) Announce the FTC Has Accepted the Consent Agreement for Public Comment More...

• Molecular Response (MRL) and Scripps Genomic Medicine Announce Joint Discovery/Development Agreement More... 

• GlaxoSmithKline (GSK) Signs Strategic Deal with MaRS innovation More... 

• GlaxoSmithKline (GSK) Seeks CROs for UK Site as Council Waits More... 

• IDBS and ChemAxon Ltd. Extend Strategic Relationship More... 

• PDI, Inc. (PDII) Announces 3 New Business Wins With Combined Total Revenues Over $5 Million More...

• Affymetrix (Santa Clara, California) (AFFX) Appoints Frank Witney, Ph.D., as President and Chief Executive Officer More... 

• GeneLink BioSciences, Inc. (GNLK) Expands its Scientific Advisory Board to Support New Product Lines More... 

• John Russell Elected to Kewaunee Scientific Corporation Board of Directors More... 

• Allscripts President Lee Shapiro Joins Medidata Solutions, Inc. Board of Directors More...

• Procter & Gamble (PG) Welcomes New Members to U.S. Sustainability Expert Advisory Panel More...

• PDL BioPharma, Inc. (PDLI) Provides Second Quarter 2011 Revenue Guidance of $128 Million More...

• Somaxon Pharmaceuticals, Inc. (SOMX) Faces Swift Attacks from Generics More...

• Teva Pharmaceutical Industries Limited (TEVA) and Pfizer Inc. (PFE) Settle Generic Neurontin(R) Litigation More...

• Bilfinger Berger Wins 30 Million EUR Deal for Work on Pfizer Inc. (PFE) Plant More... 

• FDA Reviews Blood Clot Risk with Bayer Corporation (BAY) Contraceptives More... 

• Diamyd Medical AB Closes European Phase III Study After Trial Failure More... 

• Discovery Laboratories (DSCO) Release: Analysis of Surfaxin Data Presented in First Peer-Reviewed Manuscript Describing the Consequences of Reintubation in Preterm Neonates More... 

• Cempra Pharmaceuticals, Inc. Release: Potential for Developing Fusidic Acid (TAKSTA(TM), CEM-102) in the U.S. is Profiled in Clinical Infectious Disease More... 

• Argos Therapeutics, Inc.' Arcelis(TM) Immunotherapy for the Treatment of Renal Cell Carcinoma (RCC) in Combination With Sunitinib Demonstrates Strong Immunologic Response That Correlates to Improved Clinical Outcomes More...

• Actavis Receives FDA Approval of Donepezil Hydrochloride Tablets in the U.S. More...

• FDA Grants Priority Review for Alexion Pharmaceuticals Inc. (ALXN)'s sBLA for Soliris(R) (eculizumab) as a Treatment for Patients with Atypical Hemolytic Uremic Syndrome (aHUS) More... 

• Pfizer Inc. (PFE) Asks EU to Approve Kidney Cancer Drug More... 

• Repligen Corporation (RGEN) Concludes Pre-NDA Meeting with FDA for RG1068 More... 

• Gentium S.p.A. Announces MAA for Defibrotide Accepted by EMA and Will be Reviewed by CHMP Under Accelerated Assessment More...

• Chronic-Fatigue Paper in Science Called Into Question More... 

• ACSM: Low-Carb Diet, Fatty Meal Don't Harm Arteries More... 

• Widely Used Heart Drugs Linked to Better Breast Cancer Outcomes, Study in Journal of Clinical Oncology More... 

• EULAR: Rituximab Plus Other Biologics Safe in RA More... 

• Common, Inherited Dementia May Respond to Cancer Drug, UT Southwestern Medical Center Study More...